Author:
Pilotto Sara,Carbognin Luisa,Rossi Antonio,Tortora Giampaolo,Bria Emilio
Funder
Italian Association for Cancer Research
Reference12 articles.
1. The biology and management of non-small cell lung cancer;Herbst;Nature,2018
2. Keytruda (pembrolizumab) FDA Approval History. Available at: https://www.drugs.com/history/keytruda.html (Accessed July 1, 2018).
3. European Medicines Agency - Find Medicine - Keytruda. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003820/human_med_001886.jsp&mid=WC0b01ac058001d124 (Accessed July 1, 2018).
4. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016
5. Pembrolizumab (pembro) versus platinum-based chemotherapy (chemo) as first-line therapy for advanced/metastatic NSCLC with a PD-L1 tumor proportion score (TPS) ≥ 1%: Open-label, phase 3 KEYNOTE-042 study;Lopes;J Clin Oncol,2018
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献